Cyclopentanone;5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-amine;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-N-(2-methoxyethyl)-1-methylbenzimidazole-5-carboxamide;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylic acid;ethyl 2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylate
C61H69N15O7S4 — CID 165080981
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclopentanone;5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-amine;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-N-(2-methoxyethyl)-1-methylbenzimidazole-5-carboxamide;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylic acid;ethyl 2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylate
Cyclopentanone;5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-amine;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-N-(2-methoxyethyl)-1-methylbenzimidazole-5-carboxamide;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylic acid;ethyl 2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylate (PubChem CID 165080981) has the molecular formula C61H69N15O7S4 and a molecular weight of 1252.59 g/mol. Its IUPAC name is cyclopentanone;5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-amine;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-N-(2-methoxyethyl)-1-methylbenzimidazole-5-carboxamide;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylic acid;ethyl 2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylate.
Molecular Properties
| Compound Name | Cyclopentanone;5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-amine;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-N-(2-methoxyethyl)-1-methylbenzimidazole-5-carboxamide;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylic acid;ethyl 2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylate |
|---|---|
| PubChem CID | 165080981 |
| Molecular Formula | C61H69N15O7S4 |
| Molecular Weight | 1252.59 g/mol |
| Exact Mass | 1251.44 |
| IUPAC Name | cyclopentanone;5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-amine;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-N-(2-methoxyethyl)-1-methylbenzimidazole-5-carboxamide;2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylic acid;ethyl 2-(5,6-dihydro-4H-cyclopenta[d][1,3]thiazol-2-ylamino)-1-methylbenzimidazole-5-carboxylate |
| SMILES | CCOC(=O)c1ccc2c(c1)nc(Nc1nc3c(s1)CCC3)n2C.COCCNC(=O)c1ccc2c(c1)nc(Nc1nc3c(s1)CCC3)n2C.Cn1c(Nc2nc3c(s2)CCC3)nc2cc(C(=O)O)ccc21.Nc1nc2c(s1)CCC2.O=C1CCCC1 |
| InChI | InChI=1S/C18H21N5O2S.C17H18N4O2S.C15H14N4O2S.C6H8N2S.C5H8O/c1-23-14-7-6-11(16(24)19-8-9-25-2)10-13(14)20-17(23)22-18-21-12-4-3-5-15(12)26-18;1-3-23-15(22)10-7-8-13-12(9-10)18-16(21(13)2)20-17-19-11-5-4-6-14(11)24-17;1-19-11-6-5-8(13(20)21)7-10(11)16-14(19)18-15-17-9-3-2-4-12(9)22-15;7-6-8-4-2-1-3-5(4)9-6;6-5-3-1-2-4-5/h6-7,10H,3-5,8-9H2,1-2H3,(H,19,24)(H,20,21,22);7-9H,3-6H2,1-2H3,(H,18,19,20);5-7H,2-4H2,1H3,(H,20,21)(H,16,17,18);1-3H2,(H2,7,8);1-4H2 |
| InChIKey | VCTFFCITSOCBBQ-UHFFFAOYSA-N |
| XLogP | 11.38 |
| TPSA | 286.13 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1252.59 |
| LogP ≤ 5 | 11.38 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 24 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165080981 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.